Back to all Questions

question from a user

Men living at high altitudes often have raised hematocrit levels and this is deemed normal/safe/ok. Men on TRT who get above 50% PCV are usually given orders to donate blood to lower it. What is the scientific justification that shows a man living at elevation is ok with 55% PCV, but a man on TRT at sea level needs to donate and lower it? What is scientifically/biologically different about their bloods?

AlphaMD's Answer

This is an excellent question, which requires a pretty complex answer. But the basics lie in the differences between chronic hypoxia induced erythrocytosis and exogenous testosterone induced erythrocytosis.

First, the similarities:

  1. Both cause elevated red blood cell counts without an increase in blood volume. This makes the blood thicker (increased viscosity). This means that the blood is more sludge like and has trouble making its way through the smallest blood vessels (capillaries).

  2. Both are caused by increased erythropoietin secretion, which stimulates the blood marrow to produce more red blood cells.

Now, the differences:

  1. Hypoxia only effects erythropoietin levels to raise hematocrit. Testosterone raises hematocrit through multiple mechanisms.

  2. Chronic hypoxia (high altitudes, COPD) takes a long time to develop, often several years. This gives the body some time to adjust. Testosterone induced erythrocytosis can occur in as little as 3 months. This is not enough time for the body to develop any adaptive measures.

  3. Chronic hypoxia also causes other changes, which testosterone use does not. Specifically, the body creates more significantly more capillaries. These capillaries create more pathways for the thicker blood to go through, distributing the vessel wall burden, and also creating alternative pathways if a clot were to occur.

  4. Exogenous testosterone also causes downstream effects which hypoxia does not, such as thromboxane A2 receptor density and aggregation responses. The latest studies show that increased risk of arterial clotting is low with testosterone. However, the combination of increased blood viscosity along with increased platelet activity and thrombopoiesis triggered by testosterone can raise the risk of potential clots in those who ALSO have pre-existing coagulation or fibrinolysis dysfunction.

It is important to remember that testosterone is used at a treatment for idiopathic/immune thrombocytopenic purpura (ITP) which is a problem with too few platelets causing potentially fatal bleeding.

So, the main reason why we recommend therapeutic phlebotomy/routine blood donation for men on TRT with elevated blood counts, is because unlike people at high elevations, TRT also comes with elevation in platelet counts and platelet activity. Also, remember that the TRT patient at sea level does not need the extra RBCs, but the patient at the high elevation does. Telling them to donate blood while remaining in a state of hypoxia effectively makes them anemic.

Ready to get answers?
Ask your own question today.

Get $30 off your first month’s order

Enter your email address now to receive $30 off your first month’s cost, other discounts, and additional information about TRT.

Legal Disclaimer

This website is a repository of publicly available information and is not intended to form a physician-patient relationship with any individual. The content of this website is for informational purposes only. The information presented on this website is not intended to take the place of your personal physician's advice and is not intended to diagnose, treat, cure, or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. The information should not be considered complete and should not be used in place of a visit, phone or telemedicine call, consultation or advice of your physician or other healthcare provider. Only a qualified physician in your state can determine if you qualify for and should undertake treatment.